Filing Details

Accession Number:
0000950170-24-015202
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-02-14 16:05:20
Reporting Period:
2024-02-12
Accepted Time:
2024-02-14 16:05:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1773383 Dynatrace Inc. DT () DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1537211 Thoma Bravo Fund X, L.p. C/O Thoma Bravo, L.p.
110 N. Wacker Drive, 32Nd Floor
Chicago IL 60606
No No No No
1537212 Thoma Bravo Fund X-A, L.p. C/O Thoma Bravo, L.p.
110 N. Wacker Drive, 32Nd Floor
Chicago IL 60606
No No No No
1579904 Thoma Bravo Special Opportunities Fund I, L.p. C/O Thoma Bravo, L.p.
110 N. Wacker Drive, 32Nd Floor
Chicago IL 60606
No No No No
1606286 Thoma Bravo Fund Xi, L.p. C/O Thoma Bravo, L.p.
110 N. Wacker Drive, 32Nd Floor
Chicago IL 60606
No No No No
1606287 Thoma Bravo Fund Xi-A, L.p. C/O Thoma Bravo, L.p.
110 N. Wacker Drive, 32Nd Floor
Chicago IL 60606
No No No No
1606288 Thoma Bravo Executive Fund Xi, L.p. C/O Thoma Bravo, L.p.
110 N. Wacker Drive, 32Nd Floor
Chicago IL 60606
No No No No
1722232 Thoma Bravo Partners Xi, L.p. C/O Thoma Bravo, L.p.
110 N. Wacker Drive, 32Nd Floor
Chicago IL 60606
No No No No
1783009 Thoma Bravo Partners X, L.p. C/O Thoma Bravo, L.p.
110 N. Wacker Drive, 32Nd Floor
Chicago IL 60606
No No No No
1783011 Thoma Bravo Special Opportunities Fund I Aiv, L.p. C/O Thoma Bravo, L.p.
110 N. Wacker Drive, 32Nd Floor
Chicago IL 60606
No No No No
1813487 Thoma Bravo Ugp, Llc C/O Thoma Bravo, L.p.
110 N. Wacker Drive, 32Nd Floor
Chicago IL 60606
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-02-12 14,242,929 $52.60 16,114,344 No 4 S Indirect See footnote
Common Stock Disposition 2024-02-14 2,847,726 $0.00 16,114,344 No 4 J Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See footnote
No 4 J Indirect See footnote
Footnotes
  1. On February 12, 2024, the Reporting Persons sold an aggregate of 14,242,929 shares of the Issuer's Common Stock, par value $0.001 per share, pursuant to Rule 144 under the Securities Act of 1933, as amended.
  2. After giving effect to the distribution reported on this statement, consists of 839,999 shares held directly by Thoma Bravo Fund X, L.P. ("TB Fund X"), 183,745 shares held directly by Thoma Bravo Fund X-A, L.P. ("TB Fund X-A"), 3,956,572 shares held directly by Thoma Bravo Fund XI, L.P. ("TB Fund XI"), 1,987,086 shares held directly by Thoma Bravo Fund XI-A, L.P. ("TB Fund XI-A"), 87,284 shares held directly by Thoma Bravo Executive Fund XI, L.P. ("TB Exec Fund"), 72,073 shares held directly by Thoma Bravo Special Opportunities Fund I, L.P. ("TB SOF"), 530,982 shares held directly by Thoma Bravo Special Opportunities Fund I AIV, L.P. ("TB SOF AIV"), 1,798,578 shares held directly by Thoma Bravo Partners X, L.P. ("TB Partners X"), and 6,658,025 shares held directly by Thoma Bravo Partners XI, L.P. ("TB Partners XI").
  3. Thoma Bravo Partners X, L.P. ("TB Partners X") is the general partner of each of TB Fund X, TB Fund X-A, TB SOF and TB SOF AIV. Thoma Bravo Partners XI, L.P. ("TB Partners XI") is the general partner of each of TB Fund XI, TB Fund XI-A and TB Exec Fund. Thoma Bravo UGP, LLC is the ultimate managing member of TB Partners X and TB Partners XI. By virtue of the relationships described in this footnote, Thoma Bravo UGP, LLC may be deemed to exercise voting and dispositive power with respect to the shares held by TB Fund X, TB Fund X-A, TB SOF, TB SOF AIV, TB Fund XI, TB Fund XI-A and TB Exec Fund. Each of TB Partners X, TB Partners XI and Thoma Bravo UGP, LLC disclaims beneficial ownership of the shares owned by TB Fund X, TB Fund X-A, TB SOF, TB SOF AIV, TB Fund XI, TB Fund XI-A and TB Exec Fund except to the extent of its pecuniary interest therein.
  4. Represents a distribution of (i) 175,612 shares held directly by TB SOF AIV, 24,437 shares held directly by TB SOF, 351,970 shares held directly by TB Fund X and 58,947 shares held directly by TB Fund X-A, in each case to TB Partners X, and (ii) 27,878 shares held directly by TB Exec Fund, 1,607,653 shares held directly by TB Fund XI, and 601,229 shares held directly by TB Fund XI-A, in each case to TB Partners XI.